Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GSK plc
  6. News
  7. Summary
    GSK   GB00BN7SWP63

GSK PLC

(GSK)
  Report
Real-time Estimate Cboe Europe  -  06:30 2022-11-30 am EST
1417.70 GBX   -0.01%
05:47aGSK provides an update on Blenrep (belantamab mafodotin-blmf) US marketing authorisation
AQ
01:46aGsk: morgan stanley cuts target price to 1535p from 1650p…
RE
11/29Companies not doing enough to protect nature, environmental non-profit says
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Days
:
Hours
:
Minutes
:
Seconds

GSK : Gets a Neutral rating from Barclays

09/27/2022 | 10:32am EST

Initially Neutral on the company, Barclays's analyst Emily Field maintained his recommendation. The target price is still set at GBX 1800.


ę MarketScreener with dpa-AFX Analyser 2022
All news about GSK PLC
05:47aGSK provides an update on Blenrep (belantamab mafodotin-blmf) US marketing authorisatio..
AQ
01:46aGsk: morgan stanley cuts target price to 1535p from 1650p…
RE
11/29Companies not doing enough to protect nature, environmental non-profit says
RE
11/29Gsk : New global survey reveals opportunities to address organ damage risk with people liv..
PU
11/25GSK Canada Submits Respiratory Syncytial Virus Vaccine Candidate For Regulatory Review
RE
11/25Gsk canada submits respiratory syncytial virus (rsv) vaccine can…
RE
11/25FTSE 100 flat as housing, retail stocks weigh
RE
11/24Researchers test mRNA technology for universal flu vaccine
RE
11/24Analyst recommendations: Apple, Dollar Tree, GSK...
MS
11/24GSK : Berenberg reiterates its Buy rating
MD
More news
Analyst Recommendations on GSK PLC
More recommendations
Financials
Sales 2022 29 195 M 34 955 M 34 955 M
Net income 2022 4 324 M 5 177 M 5 177 M
Net Debt 2022 14 343 M 17 173 M 17 173 M
P/E ratio 2022 12,6x
Yield 2022 4,25%
Capitalization 57 397 M 68 721 M 68 721 M
EV / Sales 2022 2,46x
EV / Sales 2023 2,36x
Nbr of Employees 90 096
Free-Float 93,7%
Chart GSK PLC
Duration : Period :
GSK plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GSK PLC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 1 417,80 GBX
Average target price 1 730,98 GBX
Spread / Average Target 22,1%
EPS Revisions
Managers and Directors
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Jon Ellis VP & Head-Technology Business Development
Tony Wood Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
GSK PLC-13.74%68 721
JOHNSON & JOHNSON2.93%460 384
ELI LILLY AND COMPANY32.42%345 817
ABBVIE INC.16.84%279 679
PFIZER, INC.-16.19%277 803
NOVO NORDISK A/S19.71%276 497